The Cannigma
OCTOBER 10, 2021
A survey carried out in 2004 found that 8.6% Other conditions in which Greek patients can seek approval for medical cannabis include HIV/AIDS and epilepsy. A demonstration in central Athens during the Global Marijuana march, an annual rally demanding the legalization of marijuana and changes in drug policies (Shutterstock).
Cannabis Law Report
JANUARY 28, 2020
In this resolution, the European Commission and the member states are urged to work on the legal framework of, and the research into, the use of cannabis for medicinal purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Joint Blog
FEBRUARY 24, 2021
Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? In a 2004 survey by the Prague Movement Disorder Centre, 25% of 339 respondents had tried a form of cannabis-based treatment. This is not the first medicinal trial of its kind.
Canna Care Docs
NOVEMBER 23, 2020
Medicinal cannabis was already approved in Montana in 2004. Initiative 65 (74%) passed over the Alternative 65A (32%)—the latter of which would have restricted medicinal cannabis to terminally ill patients. The passing initiative legalizes cannabis prescriptions for 22 medical conditions.
The Cannigma
OCTOBER 8, 2021
The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009. The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients.
Cannabis Law Report
NOVEMBER 24, 2021
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Epilepsy or epilepsies were mentioned in 39% of articles. Conclusions. Palliative care indications. Cancer pain.
Veriheal
MAY 2, 2023
Aside from isolating and synthesizing cannabis compounds and proving the plant’s medicinal potential, he also invested his efforts into proving that cannabis can treat autoimmune diseases and epilepsy. He also played a pivotal role in the development of the first FDA-approved CBD-based medication for epilepsy patients, Epidiolex.
Expert insights. Personalized for you.
98 
Let's personalize your content